Avrobio Inc | AVRO - Interest Expense On Debt

Avrobio Inc reported $482K in Interest Expense on Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US USD 29.91M 11.17M
Gilead Sciences GILD:US USD 227M 2M
Intercept Pharmaceuticals ICPT:US USD 2.81M 2.43M
IONIS PHARMACEUT IONS:US USD 1.73M 408K
Karyopharm Therapeutics KPTI:US USD 5.88M 229K
Pfizer PFE:US USD 313M 2M
Roche Holding ROG:VX 348M 92M
Sarepta Therapeutics SRPT:US USD 6.69M 8.05M